Dhrubajyoti Bandyopadhyay, Adrija Hajra, Sabyasachi Mukhopadhyay, Manas Layek, Diptak Bhowmick, Vijayan Ganeshan, Sibnarayan Sasmal, Debarati Bhar, Cankatikachoudhury and Partha Sarathi Karmakar. Prognostic Significance of Serum Uric Acid at the Time of Admission in Patients with Acute Stroke.
. 2015; 3(2):24-30. doi: 10.12691/AJCMR-3-2-2
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | The top 10 causes of death.World Health Organization.May 2014. Downloaded from-http://www.who.int/mediacentre/factsheets/fs310/en/. |
|
[2] | Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation 2012 Jan 3; 125(1):e2-e220. |
|
[3] | Fauci AS, Kasper DS, Braunwald E, Hauser SL, Longo DL, Jameson JL, Loscalzo J:Harrison’s Principle of Internal Medicine.18th edition.USA. Mc Graw Hill; 2012. |
|
[4] | Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. Uric acid as a CNS antioxidant. J Alzheimers Dis 2010;19: 1331-36. |
|
[5] | Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84. |
|
[6] | Goldman L, Ausiello D: Cecil Medicine : 23 ed |
|
[7] | Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. ClinSci 1993; 84:407-12. |
|
[8] | Waring W.S.: Uric acid: an important antioxidant in acute ischaemic stroke: Q J Med 2002; 95: 691-693. |
|
[9] | Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch BiochemBiophys 2000; 376: 333-7. |
|
[10] | Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000; 148:131-9. |
|
[11] | Chamorro Á, MD; r ObachV, MD; Cervera Á, MD; Revilla M, MD; Deulofeu R, PhD;. Aponte JH, MD: Prognostic Significance of Uric Acid Serum Concentration in Patients With Acute Ischemic Stroke. Stroke. 2002; 33: 1048-1052. |
|
[12] | Amaro S, Soy D, Obach V, Cervera A, Planas A, Chamorro A. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischaemic stroke. Stroke 2007; 38: 2173-5. |
|
[13] | Amaro S, Chamorro Ã. Translational stroke research of the combination of thrombolysis and antioxidant therapy. Stroke 2011; 42: 1495-9. |
|
[14] | Rosamond W, PhD; Flega K, PhD; Friday G, MD, MPH; Furie K, MD; Go A, MD; Greenlund K, PhD et al; Heart disease and stroke statistics – 2007 update, A report from American heart association statistics committee and stroke statistics subcommittee;; for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007; 115:e69-e171. |
|
[15] | Abuja PM. Ascorbate prevents prooxidant effects of urate in oxidation of human low density lipoprotein. FEBS Lett 1999; 446: 305-308. |
|
[16] | Editorial comment – Elevated uric acid and ischemic stroke; accumulating evidence that it is injurious not neuroprotective. |
|
[17] | H. Kenneth Walker, W. Dallas Hall, J Willis Hurst. Clinical methods: The History physical and laboratory examinations, Butterworth, 3 Ed. |
|
[18] | Amaro S,Urra X, Gómez-Choco M, Obach V,Cervera A,Vargas M et al. Stroke 2011; 2:S28-S32. |
|
[19] | Wu H, Jia Q, Liu G, Liu L, Pu Y, Zhao X, Wang C, Wang Y, Wang Y: Stroke Cerebrovascular Disc. 2013 Jun; pii: S1052-3057(13)00124-9. |
|